Download
1 / 3
0 likes | 4 Views
Digital pathology enables pathologists to collaborate and work remotely on cases by improving the accuracy of diagnostic techniques and allowing the sharing of digital images beyond geographical limitations. Before the outbreak of COVID-19, the adoption of digital pathology was extremely low due to stringent federal regulations of the U.S. FDA.
E N D
Digital Pathology Market Set to Reach $1.86 Billion by 2030: Key Drivers and Insights
Global Digital Pathology Market – 2024-2030 The digital pathology market is on track to grow significantly, with projections indicating it will reach $1.86 billion by 2030, expanding at a CAGR of 8.7%, according to the latest report by Meticulous Research®. This growth is fueled by several factors, including the rising incidence of cancer, advancements in biomarker availability and research, and an increasing number of clinical trials for oncology drugs. Additionally, the need for accurate genetic and rare disease detection, alongside the growing adoption of teleconsulting and the shift towards precision medicine, are major contributors to this market's expansion. Emerging markets further present substantial growth opportunities. Download Sample Copy: https://www.meticulousresearch.com/download-sample- report/cp_id=5433 Market Breakdown and Insights 1. Hardware Leads Offerings: In 2024, the hardware segment is projected to hold the largest share of the digital pathology market. This segment's growth is driven by the global prevalence of chronic diseases, the critical need for accurate diagnosis, and the ongoing digital transformation of pathology, which is increasing the demand for specialized hardware. • 2. Dominance of Disease Diagnosis: Disease diagnosis is expected to be the leading application within the digital pathology market by 2024. This is due to an aging global population, the widespread occurrence of chronic conditions, and the significant increase in teleconsulting, particularly after the COVID-19 pandemic. • 3. Hospitals & Clinics to Command the Market: Hospitals and clinics are anticipated to dominate the end-user segment in 2024. This is driven by the large number of healthcare facilities globally, the pressing need for digital pathology due to the high demand for pathology tests, and the ongoing research in precision medicine. • Regional Overview North America is poised to lead the digital pathology market in 2024, with the United States at the forefront. The growth in this region is driven by the digitization of pathology services, substantial investments in research and development, high adoption of advanced technologies, and the rising demand for reliable diagnostics. Page 1 of 2 © Meticulous Research| sales@meticulousresearch.com
Global Digital Pathology Market – 2024-2030 Get Customized Report: https://www.meticulousresearch.com/request- customization/cp_id=5433 Key Market Players Prominent companies in the digital pathology market include 3DHISTECH Ltd. (Hungary), Leica Microsystems (Germany), Hamamatsu Photonics K.K. (Japan), Nikon Corporation (Japan), Visiopharm A/S (Denmark), Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Glencoe Software, Inc. (U.S.), XIFIN, Inc. (U.S.), and PerkinElmer Inc. (U.S.). These market leaders continue to drive innovation, developing the tools and technologies that meet the evolving demands of the healthcare sector as digital pathology becomes increasingly vital. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 2 of 2 © Meticulous Research| sales@meticulousresearch.com
